Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 04 - 20 symbols : Jnj save search
Worldwide Skin Care Products Industry to 2026 - Featuring Unilever, Avon Products and L'Oreal Among Others
Published: 2021-04-20 (Crawled : 22:00) - prnewswire.com
UL | $47.19 0.73% 2.3M
|
Consumer Non-Durables
|
| O: -0.59%
H: 0.59%
C: 0.42%
REV | $3.8999 0.0%
|
Consumer Non-Durables
|
| O: 0.19%
H: 7.32%
C: 6.94%
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -0.07%
H: 0.32%
C: 0.13%
CL | $86.685 0.55% 1.1M
|
Consumer Non-Durables
|
| O: 0.49%
H: 0.39%
C: -0.71%
ev skin
An Update on the J&J COVID-19 Vaccine Pause: What We Know So Far
Published: 2021-04-20 (Crawled : 22:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
covid vaccine covid-19
Presidio Medical Announces New Executive Appointment
Published: 2021-04-20 (Crawled : 18:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review
Published: 2021-04-20 (Crawled : 17:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
covid europe vaccine ema
Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021
Published: 2021-04-20 (Crawled : 17:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
results
Johnson & Johnson COVID-19 Vaccine Roll-out to Resume in Europe Following European Medicines Agency (EMA) Review
Published: 2021-04-20 (Crawled : 16:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
covid europe vaccine ema
Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations
Published: 2021-04-20 (Crawled : 16:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
commercialization bioscience
COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in...
Published: 2021-04-20 (Crawled : 16:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.41%
H: 1.62%
C: 0.11%
covid antiviral research covid-19
COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in Hamsters and More
Published: 2021-04-20 (Crawled : 15:15) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.41%
H: 1.62%
C: 0.11%
covid antiviral research covid-19
2021 COVID-19 News: Researchers Discover a New Variant, Antiviral Shows Promise in Hamsters and More
Published: 2021-04-20 (Crawled : 15:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
LLY | $731.1 -1.99% 1M
|
Health Technology
|
| O: 0.41%
H: 1.62%
C: 0.11%
covid antiviral research covid-19
J&J Shareholders Urged by Others to Reject CEO's $30 Million Payday
Published: 2021-04-20 (Crawled : 14:15) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
ceo leo
Vividion Therapeutics Expands Leadership Team with Key Regulatory and CMC Appointments
Published: 2021-04-20 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
KURA | $17.455 -1.27% 300K
|
Health Technology
|
| O: 1.19%
H: 4.51%
C: 0.0%
Avicanna Announces Initial Listings and Sales for Evidence-Based RHO Phyto™ Products in Canada’s Adult Use Channels Including Ontario, Manitoba, Saskatchewan, and New Brunswick
Published: 2021-04-20 (Crawled : 12:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
sales ev
Johnson & Johnson Announces Dividend Increase of 5.0%
Published: 2021-04-20 (Crawled : 11:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
Johnson & Johnson Reports 2021 First-Quarter Results:
Published: 2021-04-20 (Crawled : 11:00) - prnewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
results
Johnson & Johnson Announces Dividend Increase of 5.0% - Apr 20, 2021
Published: 2021-04-20 (Crawled : 11:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
Johnson & Johnson Reports 2021 First-Quarter Results:
Published: 2021-04-20 (Crawled : 11:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
results
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2021
Published: 2021-04-20 (Crawled : 11:00) - globenewswire.com
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
GMAB | $28.67 1.2% 41K
|
Health Technology
|
| O: 0.87%
H: 0.53%
C: -0.45%
sales
Axion BioSystems Announces Formation of Scientific Advisory Board
Published: 2021-04-20 (Crawled : 06:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
|
| O: -1.04%
H: 4.22%
C: 3.4%
SNY | News | $46.135 1.64% 270K
|
Health Technology
|
| O: -0.08%
H: 0.42%
C: 0.42%
PASG | $1.15 -4.17% 26K
|
Health Technology
|
| O: -1.06%
H: 5.53%
C: 4.34%
Gainers vs Losers
| 80% | 20% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0606 68.33% 250M
|
NVFY | $3.45 63.51% 20M
|
Consumer Durables
CHRO | $1.73 41.22% 46K
|
n/a
ZCMD | $1.98 36.55% 27M
|
Commercial Services
RWOD | $10.61 32.68% 5.1M
|
n/a
PAPL | $2.07 26.22% 550K
|
AULT | $0.304 25.57% 47M
|
Manufacturing
WISA 4 | $7.19 22.07% 18M
|
Electronic Technology
MCB 4 | $39.53 19.43% 88K
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.